tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market
Advertisement

ImmunityBio (IBRX) Stock Investors

Compare
1,538 Followers
Based on 816,893 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold IBRX
On average, investors allocate 3.87% of their portfolios to IBRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 816,893 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IBRX

0.2%
Last 7
Days
6.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IBRX, out of 816,893 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IBRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
2.27%
$2.61
Increased
2.44%
$2.51
Opened
8.33%
$2.80
Opened
0.59%
$2.47
Opened
0.44%
$2.38
Based on the activity of investors who made their portfolios public
The table shows changes in IBRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IBRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Abbott Laboratories
3.00%
-0.43%
+0.76%
231.15B
Healthcare
Riot Platforms
4.59%
-2.01%
-4.86%
4.86B
Financial
Bristol-Myers Squibb
2.95%
-1.27%
-3.05%
95.03B
Healthcare
CVS Health
3.62%
-0.91%
+6.10%
93.46B
Ford Motor
4.93%
-1.17%
-2.33%
46.48B
Consumer Cyclical
MARA Holdings
4.47%
-0.82%
-1.72%
5.60B
Financial
Viking Therapeutics
3.56%
-1.72%
+6.09%
2.98B
Healthcare
Block
3.25%
-1.19%
-1.47%
46.18B
Technology
Nio
5.43%
-0.07%
+1.15%
12.85B
Consumer Cyclical
Lucid Group
4.42%
-1.35%
-2.41%
4.97B
Consumer Cyclical
Based on the activity of 816,893 active portfolios
Open your Smart Portfolio

IBRX Investor Analysis

IBRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.5%
of IBRX holders
are under 35
Average Segment Performance
Average P/E Ratio28.59
Beta0.87
Dividend Yield4.85%
IBRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
48.7%
of IBRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio25.27
Beta5.39
Dividend Yield6.55%
IBRX investors over 55

Over 55

6.4%
Last 30 days
Holdings Change
40.8%
of IBRX holders
are over 55
Average Segment Performance
Average P/E Ratio23.83
Beta2.25
Dividend Yield3.84%
Overview of age group and performance of IBRX stock investors
See who invests in IBRX according to age group and performance.

FAQ

How many retail Investors hold IBRX?
0.1% of TipRanks' retail investors hold IBRX in their portfolios.
    What is IBRX Investor Sentiment?
    IBRX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of IBRX in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of IBRX in the last 7 days.
        What percentage of retail investors changed their holding of IBRX in the last 30 days?
        ▲ 6.9% of TipRanks' retail investors changed their holding of IBRX in the last 30 days.
          What is the average age of retail investors who hold IBRX?
          The average age of IBRX Holders is between 35–55.
            What other stocks have IBRX investors also bought?
            IBRX Investors also bought ABT, RIOT, BMY, CVS, F, MARA, VKTX, XYZ, NIO, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis